Nuveen’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Nuveen’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-309,118	Closed	-$10.3M	–	3375
2024 Q3	$10.3M	Buy	309,118 +149,129	+93%	+$5.13M	﹤0.01%	1581
2024 Q2	$4.32M	Buy	159,989 +20,094	+14%	+$396K	﹤0.01%	2029
2024 Q1	$3.02M	Buy	139,895 +115,549	+475%	+$2.52M	﹤0.01%	2206
2023 Q4	$147K	Buy	24,346 +2,534	+12%	+$12.6K	﹤0.01%	3249
2023 Q3	$121K	Hold	21,812	–	–	﹤0.01%	3110
2023 Q2	$160K	Buy	+21,812	New	+$165K	﹤0.01%	3121

Nuveen's LBPH Position: Q4 2024 in Review

Nuveen sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 309,118 shares — an estimated $10.3M sold.

Nuveen first reported a position in LBPH in Q2 2023 and held it in 6 quarters. The position peaked at $10.3M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Nuveen reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Nuveen sold 309,118 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $10.3M.
Nuveen first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
Nuveen's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $10.3M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Nuveen's 13F filing for Q4 2024, filed 14 Feb 2025.